Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-03-10 3:12 pm Sale |
2021-02-28 | 13G | Syros Pharmaceuticals, Inc. SYRS |
ARK Investment Management LLC | 858,960 13.940% |
-45,172 (-5.00%) |
Filing History |
| 2021-02-16 4:33 pm Sale |
2020-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS |
ARK Investment Management LLC | 904,132 19.740% |
-217,119 (-19.36%) |
Filing History |
| 2021-02-16 3:12 pm Sale |
2020-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Point72 Asset Management, L.P. | 3,969 0.100% |
-227,548 (-98.29%) |
Filing History |
| 2021-02-11 5:27 pm Sale |
2020-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Nikko Asset Management Americas, Inc. | 438,199 9.570% |
-59,267 (-11.91%) |
Filing History |
| 2021-02-08 10:33 am Purchase |
2021-02-05 | 13G | Syros Pharmaceuticals, Inc. SYRS |
FMR CORP | 691,234 14.999% |
50,543 (+7.89%) |
Filing History |
| 2021-02-05 06:10 am Sale |
2020-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Sumitomo Mitsui Trust Group, Inc. | 438,199 9.570% |
-59,267 (-11.91%) |
Filing History |
| 2021-02-02 5:02 pm Sale |
2020-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS |
ARCH Venture Fund VII L.P. | 0 0.000% |
-334,177 (Position Closed) |
Filing History |
| 2021-02-01 08:23 am Purchase |
2020-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS |
BLACKROCK INC BLK |
332,556 7.300% |
46,215 (+16.14%) |
Filing History |
| 2020-12-18 4:20 pm Purchase |
2020-12-08 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Ally Bridge MedAlpha Master Fund L.P. | 303,313 5.400% |
303,313 (New Position) |
Filing History |
| 2020-12-14 5:12 pm Purchase |
2020-12-08 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Bain Capital Life Sciences Fund II, L.P. | 578,504 11.000% |
578,504 (New Position) |
Filing History |
| 2020-10-09 2:16 pm Purchase |
2020-06-30 | 13G | Syros Pharmaceuticals, Inc. SYRS |
ARK Investment Management LLC | 1,121,251 24.500% |
613,470 (+120.81%) |
Filing History |